Yuling Luo is the founder of Alamar Biosciences. Alamar Biosciences has raised $250M in total funding. Latest round: Series C. Backed by Sands Capital.
Yuling Luo, PhD, is co-founder and CEO of Alamar Biosciences, a company dedicated to enhancing early disease detection through innovative protein detection technology used in Alzheimer's and cancer research. A serial entrepreneur, he has secured $250 million to advance his approach, expanding Alamar Biosciences from five to 140 employees since its Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library